Allstate Corp Regeneron Pharmaceuticals, Inc. Transaction History

Allstate Corp

$1.02 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $5,416 - $5,960	-6 Reduced 1.66%	355 $341,000
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $7,751 - $8,817	-10 Reduced 2.7%	361 $317,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $1,400 - $1,660	-2 Reduced 0.54%	371 $266,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $2.69 Million - $3.27 Million	-3,950 Reduced 91.37%	373 $306,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $53,647 - $58,245	76 Added 1.79%	4,323 $3.12 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $114,794 - $144,864	200 Added 4.94%	4,247 $2.93 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $72,382 - $97,526	-132 Reduced 3.16%	4,047 $2.39 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $3 Million - $3.52 Million	-5,042 Reduced 54.68%	4,179 $2.92 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $4.61 Million - $5.69 Million	8,478 Added 1141.05%	9,221 $5.82 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $97,585 - $115,763	-170 Reduced 18.62%	743 $450,000
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $174,463 - $206,101	-369 Reduced 28.78%	913 $510,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $43,332 - $53,175	97 Added 8.19%	1,282 $607,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $364,464 - $463,280	-762 Reduced 39.14%	1,185 $572,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $542,571 - $655,577	-996 Reduced 33.84%	1,947 $1.09 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $420,308 - $548,619	852 Added 40.75%	2,943 $1.84 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $702,952 - $1.03 Million	2,091 New	2,091 $1.02 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $1.72 Million - $2.38 Million	-5,742 Closed	0 $0
Q1 2019 May 20, 2019	BUY	$372.08 - $439.57 $221,387 - $261,544	595 Added 11.56%	5,742 $2.36 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $1.73 Million - $2.07 Million	5,147 New	5,147 $1.92 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account